Although their purposes are similar, their mechanisms, benefits, and usage differ
By infusing the nutrients intravenously, we bypass the gastrointestinal (GI) system where the acidic environment of the stomach, difficulty of intestinal absorption, and liver metabolism may lead to as little as 20-30% absorption of oral supplements
Because preclinical reports describe activity on fat-cell metabolism without stimulating IGF-1 production, AOD-9604 is studied as a way to separate GH's metabolic effects from its growth-promoting effects
Semaglutide can cause GI discomfort that changes with dose and is usually easy to control with titration methods
In contrast, FOXO4-DRI treatment significantly reduced the cell number in the PDL9 group (Supplementary Figures 1, 2)
This modified continuous approach provides regular breaks without extended time off